The Centers for Disease Control and Prevention (CDC) has officially recommended expanding the eligibility of booster doses of the Pfizer-BioNTech COVID-19 vaccine to teenagers 12-17 years of age.
The decision came hours after the agency’s Advisory Committee on Immunization Practices (ACIP) voted to support the action Wednesday.
At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 12-17.
Earlier in the week, the agency shortened the interval from six months to five months for when people are eligible for a booster dose of the Pfizer-BioNTech COVID-19 vaccine. The CDC also recommended that moderately or severely immunocompromised 5-11-year-olds receive an additional primary dose of vaccine 28 days after their second shot.
